These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38391563)

  • 41. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
    Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
    EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
    Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
    J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
    [No Abstract]   [Full Text] [Related]  

  • 43. Screening of Natural Products and Derivatives for the Identification of RND Efflux Pump Inhibitors.
    Choudhury D; Talukdar AD; Chetia P; Bhattacharjee A; Choudhury MD
    Comb Chem High Throughput Screen; 2016; 19(9):705-713. PubMed ID: 27450181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.
    Middlemiss JK; Poole K
    J Bacteriol; 2004 Mar; 186(5):1258-69. PubMed ID: 14973037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae.
    DeSarno AE; Parcell BJ; Coote PJ
    Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33053176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Suresh M; Nithya N; Jayasree PR; Vimal KP; Manish Kumar PR
    World J Microbiol Biotechnol; 2018 May; 34(6):83. PubMed ID: 29846800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of antibiotic resistance by efflux in clinical isolates of Pseudomonas aeruginosa.
    Abdi-Ali A; Rahmani-Badi A; Falsafi T; Nikname V
    Pak J Biol Sci; 2007 Mar; 10(6):924-7. PubMed ID: 19069890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two Regulators, PA3898 and PA2100, Modulate the Pseudomonas aeruginosa Multidrug Resistance MexAB-OprM and EmrAB Efflux Pumps and Biofilm Formation.
    Heacock-Kang Y; Sun Z; Zarzycki-Siek J; Poonsuk K; McMillan IA; Chuanchuen R; Hoang TT
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.
    Pacios O; Fernández-García L; Bleriot I; Blasco L; González-Bardanca M; López M; Fernández-Cuenca F; Oteo J; Pascual Á; Martínez-Martínez L; Domingo-Calap P; Bou G; Tomás M;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0090021. PubMed ID: 34228538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa.
    Horna G; López M; Guerra H; Saénz Y; Ruiz J
    Sci Rep; 2018 Nov; 8(1):16463. PubMed ID: 30405166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
    Hill L; Veli N; Coote PJ
    Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin
    Wang L; Zhang Y; Lin Y; Cao J; Xu C; Chen L; Wang Y; Sun Y; Zheng X; Liu Y; Zhou T
    Microbiol Spectr; 2023 Feb; 11(1):e0199222. PubMed ID: 36475724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa.
    Zhao Q; Li XZ; Mistry A; Srikumar R; Zhang L; Lomovskaya O; Poole K
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2225-31. PubMed ID: 9736539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant
    Zhang X; Zhao Y; Feng L; Xu M; Ge Y; Wang L; Zhang Y; Cao J; Sun Y; Wu Q; Zhou T
    Front Microbiol; 2021; 12():790220. PubMed ID: 34899672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Two Sets of RND-Type Multidrug Efflux Pump Transporter Genes,
    Ichinose Y; Nishimura T; Harada M; Kashiwagi R; Yamamoto M; Noutoshi Y; Toyoda K; Taguchi F; Takemoto D; Matsui H
    Plant Pathol J; 2020 Apr; 36(2):148-156. PubMed ID: 32296294
    [No Abstract]   [Full Text] [Related]  

  • 58. Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition.
    Siriyong T; Murray RM; Bidgood LE; Young SA; Wright F; Parcell BJ; Voravuthikunchai SP; Coote PJ
    Sci Rep; 2019 Jun; 9(1):9098. PubMed ID: 31235728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.